RPS6KB1 and neoplasm: On the other hand, metformin was reported to affect several other intracellular pathways in tumor cells, including HER1/HER2, Src, S6K1, c-MYC, and STAT3 among others [16, 24-27], being also able to overcome dietary restriction-resistance in cancer cells [28].